Evidence map›Paper›PMID 35951581›Full record

ArticleACS chemical biology2022

Revving an Engine of Human Metabolism: Activity Enhancement of Triosephosphate Isomerase via Hemi-Phosphorylation.

Luis F Schachner, Benjamin Des Soye, Soo Ro, Grace E Kenney, Ashley N Ives, Taojunfeng Su, Young Ah Goo, Michael C Jewett, Amy C Rosenzweig, Neil L Kelleher

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Does the Type of Semen Affect the Phosphoproteome of Turkey (International journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Characterization of the enzyme kinetics of EMP and HMP pathway inFrontiers in bioengineering and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Luis F SchachnerDepartment of Chemistry, the Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States.ORCID 0000-0001-6157-0937
Benjamin Des SoyeDepartment of Chemistry, the Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States.ORCID 0000-0001-5480-4192
Soo RoDepartment Molecular and Biological Sciences, Northwestern University, Evanston, Illinois 60208, United States.
Grace E KenneyDepartment Molecular and Biological Sciences, Northwestern University, Evanston, Illinois 60208, United States.ORCID 0000-0002-9579-3351
Ashley N IvesDepartment of Chemistry, the Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States.ORCID 0000-0002-1318-5732
Taojunfeng SuDepartment of Chemistry, the Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States.
Young Ah GooDepartment of Chemistry, the Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States.
Michael C JewettDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois 60208, United States.ORCID 0000-0003-2948-6211
Amy C RosenzweigDepartment Molecular and Biological Sciences, Northwestern University, Evanston, Illinois 60208, United States.ORCID 0000-0001-8472-4134
Neil L KelleherDepartment of Chemistry, the Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States.ORCID 0000-0002-8815-3372
Northwestern University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1993 to 2026
$153.9M
The UIUC Neuroproteomics Center on Cell-Cell SignalingP30DA018310 · NIDA · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI Elena V Romanova · 2004 to 2026
$24.9M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007028 · NIEHS · VANDERBILT UNIVERSITY · PI F PETER Guengerich, Fiona Edith Harrison · 1985 to 2026
$15.7M
TR&D 7: Cell Specific ProteomicsP41GM108569 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2015 to 2024
$13.6M
Tennessee Valley Cooperative Human Tissue NetworkUM1CA183727 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2014 to 2026
$12.6M
Metalloenzymes and metal homeostasisR35GM118035 · NIGMS · NORTHWESTERN UNIVERSITY · PI AMY C. ROSENZWEIG · 2016 to 2026
$7.1M
Vanderbilt University Biomolecular Multimodal Imaging Center for 3-Dimensional Tissue MappingU54DK120058 · NIDDK · VANDERBILT UNIVERSITY · PI HARRIS, RAYMOND C. · 2018 to 2021
$5.7M
Defining native proteoform landscape for amyloid-beta in Alzheimers diseaseRF1AG063903 · NIA · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L, KLEIN, WILLIAM L · 2019 to 2019
$2.9M
Chemistry of Life Processes Predoctoral Training ProgramT32GM105538 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2013 to 2022
$2.7M
Renewable and Specific Affinity Reagents for Mapping Proteoforms in Human TissuesUH3CA246635 · NCI · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2019 to 2021
$1.4M
Novel Platform for Quantitative Subcellular Resolution Imaging of Human Tissues Using Mass SpectrometryUH3CA255132 · NCI · PURDUE UNIVERSITY · PI LASKIN, JULIA · 2020 to 2021
$1.3M
Acquisition of a Thermo Fisher Scientific Q Exactive UHMR mass spectrometerS10OD025194 · OD · NORTHWESTERN UNIVERSITY · PI COMPTON, PHILIP DANIEL · 2018 to 2018
$795k
NCI NIH HHS F32 CA246894NCI NIH HHS P30 CA060553NCI NIH HHS UH3 CA246635NCI NIH HHS UH3 CA255132NCI NIH HHS UM1 CA183727NIA NIH HHS RF1 AG063903NIDA NIH HHS P30 DA018310NIDDK NIH HHS U54 DK120058NIEHS NIH HHS T32 ES007028NIGMS NIH HHS P41 GM108569NIGMS NIH HHS R35 GM118035NIGMS NIH HHS T32 GM105538NIH HHS S10 OD025194
6 · The paper itself

Abstract

Triosephosphate isomerase (TPI) performs the 5th step in glycolysis, operates near the limit of diffusion, and is involved in "moonlighting" functions. Its dimer was found singly phosphorylated at Ser20 (pSer20) in human cells, with this post-translational modification (PTM) showing context-dependent stoichiometry and loss under oxidative stress. We generated synthetic pSer20 proteoforms using cell-free protein synthesis that showed enhanced TPI activity by 4-fold relative to unmodified TPI. Molecular dynamics simulations show that the phosphorylation enables a channel to form that shuttles substrate into the active site. Refolding, kinetic, and crystallographic analyses of point mutants including S20E/G/Q indicate that hetero-dimerization and subunit asymmetry are key features of TPI. Moreover, characterization of an endogenous human TPI tetramer also implicates tetramerization in enzymatic regulation. S20 is highly conserved across eukaryotic TPI, yet most prokaryotes contain E/D at this site, suggesting that phosphorylation of human TPI evolved a new switch to optionally boost an already fast enzyme. Overall, complete characterization of TPI shows how endogenous proteoform discovery can prioritize functional versus bystander PTMs.

Indexed as

Molecular Dynamics SimulationTriose-Phosphate IsomeraseCatalytic DomainHumansKineticsPhosphorylationTriose-Phosphate Isomerase

Identifiers

PMID35951581
PMCPMC9588721
OpenAlexW4290964448

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.